Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Shockwave Medical Inc (SWAV)

Shockwave Medical Inc (SWAV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,022,444
  • Shares Outstanding, K 35,792
  • Annual Sales, $ 237,150 K
  • Annual Income, $ -9,140 K
  • 60-Month Beta 1.06
  • Price/Sales 39.07
  • Price/Cash Flow N/A
  • Price/Book 30.37
Trade SWAV with:

Options Overview Details

View History
  • Implied Volatility 63.21% ( +4.17%)
  • Historical Volatility 47.65%
  • IV Percentile 60%
  • IV Rank 38.06%
  • IV High 96.87% on 05/09/22
  • IV Low 42.53% on 08/18/22
  • Put/Call Vol Ratio 0.29
  • Today's Volume 412
  • Volume Avg (30-Day) 500
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 10,502
  • Open Int (30-Day) 11,266

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 0.68
  • Number of Estimates 5
  • High Estimate 0.80
  • Low Estimate 0.59
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +1,260.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
245.03 +2.88%
on 09/23/22
314.90 -19.95%
on 08/29/22
-47.11 (-15.75%)
since 08/23/22
3-Month
186.00 +35.53%
on 07/13/22
314.90 -19.95%
on 08/29/22
+66.06 (+35.51%)
since 06/23/22
52-Week
113.36 +122.37%
on 05/09/22
314.90 -19.95%
on 08/29/22
+24.40 (+10.72%)
since 09/23/21

Most Recent Stories

More News
Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod

Stryker's (SYK) OptaBlate bone tumor ablation system is set to offer a reliable solution for people living with painful metastatic tumors.

SYK : 206.93 (-0.93%)
MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
SWAV : 252.08 (-2.61%)
Bruker (BRKR) Gains From New Product Bookings Amid Competition

Bruker's (BRKR) revenue recognition from one gigahertz class NMR system and continued uptake of the timsTOF platform hold promise.

MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
BRKR : 49.52 (-0.40%)
SWAV : 252.08 (-2.61%)
Walgreens Boots' (WBA) Product Expansion Aids Amid Rivalry

Sales contributions from Walgreens Boots' (WBA) newly-formed Walgreens Health segment instill investors' optimism.

MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
WBA : 32.83 (-1.47%)
SWAV : 252.08 (-2.61%)
Here's Why Investors Should Retain Amedisys (AMED) Stock for Now

Investors are optimistic about Amedisys' (AMED) better-than-expected earnings and notable buyouts.

AMED : 106.11 (-1.57%)
MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
SWAV : 252.08 (-2.61%)
PerkinElmer's (PKI) Reagent Kit Receives FDA Clearance

PerkinElmer's (PKI) T-Cell Select reagent kit is expected to allow for a more automated workflow following the FDA's approval.

MCK : 343.27 (-1.06%)
PKI : 122.31 (-0.75%)
AMN : 103.95 (-0.15%)
SWAV : 252.08 (-2.61%)
Here's Why You Should Retain QIAGEN (QGEN) Stock for Now

Investors are optimistic about QIAGEN's (QGEN) better-than-expected results and solid genomics uptake.

MCK : 343.27 (-1.06%)
QGEN : 41.32 (-1.27%)
AMN : 103.95 (-0.15%)
SWAV : 252.08 (-2.61%)
Abbott (ABT) Reports Favorable Findings From RELIEF Study

The latest data from the RELIEF Study suggests a lower rate of hospitalizations from serious diabetes-related events with Abbott's (ABT) FreeStyle Libre system.

ABT : 100.68 (-0.39%)
MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
SWAV : 252.08 (-2.61%)
3 Reasons to Retain NextGen (NXGN) Stock in Your Portfolio

NextGen's (NXGN) strong product portfolio and solid prospects in the RCM space raise optimism about the stock.

MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
NXGN : 16.91 (-0.65%)
SWAV : 252.08 (-2.61%)
Here's Why You Should Bet on ShockWave Medical (SWAV) Stock

ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment to clinical studies.

MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
SMLR : 36.72 (-1.21%)
SWAV : 252.08 (-2.61%)
Here's Why You Should Buy McKesson (MCK) Stock Right Now

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

MCK : 343.27 (-1.06%)
AMN : 103.95 (-0.15%)
HCA : 191.50 (-1.32%)
SWAV : 252.08 (-2.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ShockWave Medical, Inc. is a medical device company. It is focused on developing and commercializing products for medical device treatment of atherosclerotic cardiovascular disease. ShockWave Medical, Inc. is based in Santa Clara, United States.

See More

Key Turning Points

3rd Resistance Point 265.94
2nd Resistance Point 260.35
1st Resistance Point 256.21
Last Price 252.08
1st Support Level 246.49
2nd Support Level 240.90
3rd Support Level 236.76

See More

52-Week High 314.90
Last Price 252.08
Fibonacci 61.8% 237.91
Fibonacci 50% 214.13
Fibonacci 38.2% 190.35
52-Week Low 113.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar